- Home
- STRO vs API Comparison
STRO vs API Comparison
Compare STRO & API Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STRO | API |
|---|---|---|
| Founded | 2003 | 2013 |
| Country | United States | United States |
| Employees | 133 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 491.0M | 406.7M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | STRO | API |
|---|---|---|
| Price | $30.28 | $4.01 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $31.33 | N/A |
| AVG Volume (30 Days) | 388.4K | ★ 425.7K |
| Earning Date | 05-11-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $13.46 |
| Revenue Next Year | N/A | $12.87 |
| P/E Ratio | ★ N/A | $92.30 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.72 | $3.14 |
| 52 Week High | $43.85 | $5.50 |
Technical Indicators
Market Signals| Indicator | STRO | API |
|---|---|---|
| Relative Strength Index (RSI) | 50.85 | 44.98 |
| Support Level | $23.53 | $3.68 |
| Resistance Level | $30.94 | $4.01 |
| Average True Range (ATR) | 2.75 | 0.24 |
| MACD | 0.41 | -0.05 |
| Stochastic Oscillator | 53.05 | 31.28 |
Price Performance
Historical ComparisonAbout STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About API Agora Inc.
Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.